SCHEMBL16482513

SCHEMBL16482513

O=[N+]([O-])c1cc(-n2c3ccccc3c3ccccc32)ccc1-c1cccc2c1sc1ccccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP14 Q460N5 1/20 0.39
▸ ALOX5 P09917 1/20 0.38
▸ PRKDC P78527 5/20 0.38
▸ PIK3CD O00329 2/20 0.36
▸ PIK3CB P42338 2/20 0.36
▸ BRD4 O60885 1/20 0.36
▸ PIK3CA P42336 1/20 0.36
▸ MTOR P42345 1/20 0.36
▸ PIK3CG P48736 1/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ BRDT Q58F21 1/20 0.36
▸ MEN1 O00255 4/20 0.36
▸ KMT2A Q03164 4/20 0.36
▸ NPC1 O15118 3/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ PDE4A P27815 1/20 0.34
▸ PDE4B Q07343 1/20 0.34
▸ PDE4C Q08493 1/20 0.34
▸ PDE4D Q08499 1/20 0.34
▸ POLB P06746 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21914404 0.81 ALOX5 (0.46) PARP14ALOX5PRKDCPIK3CDPIK3CB
SCHEMBL26511058 0.81 ALOX5 (0.46) PARP14ALOX5PRKDCPIK3CDPIK3CB
SCHEMBL4554345 0.80 PARP14 (0.49) PARP14ALOX5PRKDCPIK3CDPIK3CB
SCHEMBL4554339 0.80 PARP14 (0.42) PARP14ALOX5PRKDCNPC1RAB9A
SCHEMBL10043646 0.80 PARP14 (0.42) PARP14ALOX5PRKDCPIK3CDPIK3CB
SCHEMBL14653418 0.80 PARP14 (0.42) PARP14ALOX5PRKDCPIK3CDPIK3CB
SCHEMBL17548767 0.79 ALDH1A1 (0.34) MEN1KMT2APDE4APDE4BPDE4C
SCHEMBL21915063 0.79 ALOX5 (0.44) PARP14ALOX5PRKDCPIK3CDPIK3CB
SCHEMBL21915061 0.79 ALOX5 (0.44) PARP14ALOX5PRKDCPIK3CDPIK3CB
SCHEMBL21915062 0.79 KDM4E (0.42) PARP14ALOX5PRKDCPIK3CDPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230322802-A1 LIGHT EMITTING DEVICE AND FUSED POLYCYCLIC COMPOUND FOR THE LIGHT EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-12 — — US disclosed
US-20230322802-A1 LIGHT EMITTING DEVICE AND FUSED POLYCYCLIC COMPOUND FOR THE LIGHT EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-12 — — US disclosed
WO-2014057659-A1 COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME 出光興産株式会社 (JP) 2014-04-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230322802-A1 LIGHT EMITTING DEVICE AND FUSED POLYCYCLIC COMPOUND FOR THE LIGHT EMITTING DEVICE CRY1, LAGE3, CRY2 PARP14 1186/4885ALOX5 3627/4885PRKDC 2832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback